Dissecting the human serum antibody response to secondary dengue virus infections.
Dengue viruses (DENVs) are mosquito-borne flaviviruses and the causative agents of dengue fever and dengue hemorrhagic fever. As there are four serotypes of DENV (DENV1-4), people can be infected multiple times, each time with a new serotype. Primary infections stimulate antibodies that mainly neutr...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-05-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC5444852?pdf=render |
id |
doaj-b1f9001c3b3f4fec9a5ded8cdf8e77d9 |
---|---|
record_format |
Article |
spelling |
doaj-b1f9001c3b3f4fec9a5ded8cdf8e77d92020-11-24T21:58:51ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352017-05-01115e000555410.1371/journal.pntd.0005554Dissecting the human serum antibody response to secondary dengue virus infections.Bhumi PatelPatti LongoMichael J MileyMagelda MontoyaEva HarrisAravinda M de SilvaDengue viruses (DENVs) are mosquito-borne flaviviruses and the causative agents of dengue fever and dengue hemorrhagic fever. As there are four serotypes of DENV (DENV1-4), people can be infected multiple times, each time with a new serotype. Primary infections stimulate antibodies that mainly neutralize the serotype of infection (type-specific), whereas secondary infections stimulate responses that cross-neutralize 2 or more serotypes. Previous studies have demonstrated that neutralizing antibodies induced by primary infections recognize tertiary and quaternary structure epitopes on the viral envelope (E) protein that are unique to each serotype. The goal of the current study was to determine the properties of neutralizing antibodies induced after secondary infection with a different (heterotypic) DENV serotypes. We evaluated whether polyclonal neutralizing antibody responses after secondary infections consist of distinct populations of type-specific antibodies to each serotype encountered or a new population of broadly cross-neutralizing antibodies. We observed two types of responses: in some individuals exposed to secondary infections, DENV neutralization was dominated by cross-reactive antibodies, whereas in other individuals both type-specific and cross-reactive antibodies contributed to neutralization. To better understand the origins of type-specific and cross-reactive neutralizing antibodies, we analyzed sera from individuals with well-documented sequential infections with two DENV serotypes only. These individuals had both type-specific and cross-reactive neutralizing antibodies to the 2 serotypes responsible for infection and only cross-reactive neutralizing antibodies to other serotypes. Collectively, the results demonstrate that the quality of neutralizing (and presumably protective) antibodies are different in individuals depending on the number of previous exposures to different DENV serotypes. We propose a model in which low affinity, cross-reactive antibody secreting B-cell clones induced by primary exposure evolve during each secondary infection to secrete higher affinity and more broadly neutralizing antibodies.http://europepmc.org/articles/PMC5444852?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bhumi Patel Patti Longo Michael J Miley Magelda Montoya Eva Harris Aravinda M de Silva |
spellingShingle |
Bhumi Patel Patti Longo Michael J Miley Magelda Montoya Eva Harris Aravinda M de Silva Dissecting the human serum antibody response to secondary dengue virus infections. PLoS Neglected Tropical Diseases |
author_facet |
Bhumi Patel Patti Longo Michael J Miley Magelda Montoya Eva Harris Aravinda M de Silva |
author_sort |
Bhumi Patel |
title |
Dissecting the human serum antibody response to secondary dengue virus infections. |
title_short |
Dissecting the human serum antibody response to secondary dengue virus infections. |
title_full |
Dissecting the human serum antibody response to secondary dengue virus infections. |
title_fullStr |
Dissecting the human serum antibody response to secondary dengue virus infections. |
title_full_unstemmed |
Dissecting the human serum antibody response to secondary dengue virus infections. |
title_sort |
dissecting the human serum antibody response to secondary dengue virus infections. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS Neglected Tropical Diseases |
issn |
1935-2727 1935-2735 |
publishDate |
2017-05-01 |
description |
Dengue viruses (DENVs) are mosquito-borne flaviviruses and the causative agents of dengue fever and dengue hemorrhagic fever. As there are four serotypes of DENV (DENV1-4), people can be infected multiple times, each time with a new serotype. Primary infections stimulate antibodies that mainly neutralize the serotype of infection (type-specific), whereas secondary infections stimulate responses that cross-neutralize 2 or more serotypes. Previous studies have demonstrated that neutralizing antibodies induced by primary infections recognize tertiary and quaternary structure epitopes on the viral envelope (E) protein that are unique to each serotype. The goal of the current study was to determine the properties of neutralizing antibodies induced after secondary infection with a different (heterotypic) DENV serotypes. We evaluated whether polyclonal neutralizing antibody responses after secondary infections consist of distinct populations of type-specific antibodies to each serotype encountered or a new population of broadly cross-neutralizing antibodies. We observed two types of responses: in some individuals exposed to secondary infections, DENV neutralization was dominated by cross-reactive antibodies, whereas in other individuals both type-specific and cross-reactive antibodies contributed to neutralization. To better understand the origins of type-specific and cross-reactive neutralizing antibodies, we analyzed sera from individuals with well-documented sequential infections with two DENV serotypes only. These individuals had both type-specific and cross-reactive neutralizing antibodies to the 2 serotypes responsible for infection and only cross-reactive neutralizing antibodies to other serotypes. Collectively, the results demonstrate that the quality of neutralizing (and presumably protective) antibodies are different in individuals depending on the number of previous exposures to different DENV serotypes. We propose a model in which low affinity, cross-reactive antibody secreting B-cell clones induced by primary exposure evolve during each secondary infection to secrete higher affinity and more broadly neutralizing antibodies. |
url |
http://europepmc.org/articles/PMC5444852?pdf=render |
work_keys_str_mv |
AT bhumipatel dissectingthehumanserumantibodyresponsetosecondarydenguevirusinfections AT pattilongo dissectingthehumanserumantibodyresponsetosecondarydenguevirusinfections AT michaeljmiley dissectingthehumanserumantibodyresponsetosecondarydenguevirusinfections AT mageldamontoya dissectingthehumanserumantibodyresponsetosecondarydenguevirusinfections AT evaharris dissectingthehumanserumantibodyresponsetosecondarydenguevirusinfections AT aravindamdesilva dissectingthehumanserumantibodyresponsetosecondarydenguevirusinfections |
_version_ |
1725850519046455296 |